Macroamylasemia
Symptoms, Doctors, Treatments, Advances & More

Learn About Macroamylasemia

What is the definition of Macroamylasemia?

Macroamylasemia is the presence of an abnormal substance called macroamylase in the blood.

What are the causes of Macroamylasemia?

Macroamylase is a substance that consists of an enzyme, called amylase, attached to a protein. Because it is large, macroamylase is filtered very slowly from the blood by the kidneys.

Most people with macroamylasemia do not have a serious disease that is causing it, but the condition has been associated with:

  • Celiac disease
  • Lymphoma
  • HIV infection
  • Monoclonal gammopathy
  • Rheumatoid arthritis
  • Ulcerative colitis
What are the symptoms of Macroamylasemia?

Macroamylasemia does not cause symptoms.

Not sure about your diagnosis?
Check Your Symptoms
Who are the top Macroamylasemia Local Doctors?
Distinguished in Macroamylasemia
Family Medicine
Distinguished in Macroamylasemia
Family Medicine

Germantown Health Center

W168 N11237 Western Ave., 
Germantown, WI 
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Amy Miller is a primary care provider, practicing in Family Medicine in Germantown, Wisconsin. Dr. Miller is rated as a Distinguished provider by MediFind in the treatment of Macroamylasemia. She is also highly rated in 54 other conditions, according to our data. Her clinical expertise encompasses Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, and High Cholesterol. Dr. Miller is board certified in Family Medicine. Dr. Miller is currently accepting new patients.

Advanced in Macroamylasemia
Internal Medicine
Advanced in Macroamylasemia
Internal Medicine

Corewell Health Internal Medicine - 4069 Lake Dr SE

4069 Lake Drive Southeast, Suite 315, 
Grand Rapids, MI 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Kristin Essenberg is a primary care provider, practicing in Internal Medicine in Grand Rapids, Michigan. Dr. Essenberg is rated as an Advanced provider by MediFind in the treatment of Macroamylasemia. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Osteopenia, Melorheostosis with Osteopoikilosis, Melorheostosis, and Postmenopausal Osteoporosis. Dr. Essenberg is board certified in American Board Of Internal Medicine and American Osteopathic Board Of Internal Medicine. Dr. Essenberg is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Macroamylasemia
Family Medicine
Advanced in Macroamylasemia
Family Medicine

Texas Health Family Care

10900 Founders Way, Suite 103, 
Fort Worth, TX 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

William Drake is a primary care provider, practicing in Family Medicine in Fort Worth, Texas. Dr. Drake is rated as an Advanced provider by MediFind in the treatment of Macroamylasemia. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Cirrhosis, Familial Combined Hyperlipidemia, Xanthoma, and High Cholesterol. Dr. Drake is currently accepting new patients.

What are the latest Macroamylasemia Clinical Trials?
Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety

Summary: Recent evidence suggests that postoperative hyperamylasemia (POH) is a predictor of morbidity after pancreatectomy. This is based on the assumption that pancreatitis after pancreatectomy (PPAP) is a major trigger for the development of complications and is indicated by hyperamylasemia. Standardized prospective analysis and correlation with other laboratory parameters, hasn't been performed to date...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Early Versus Late Pancreatic Stent Placement for Preventing Post-ERCP Pancreatitis: a Multicentre, Randomised Trial

Summary: Our aim is to compare early versus late pancreatic stent placement in preventing PEP among patients with naive papilla. The EVL trial will provide essential answers regarding the optimal timing of prophylactic pancreatic stent placement in PEP prevention.All patients with difficult biliary cannulation undergoing endoscopic retrograde cholangiopancreatography (ERCP) with pancreatic guidewire-assist...

Who are the sources who wrote this article ?

Published Date: October 20, 2025
Published By: Todd Eisner, MD, Private practice specializing in Gastroenterology in Boca Raton and Delray Beach, Florida at Gastroenterology Consultants of Boca Raton. Affiliate Assistant Professor, Florida Atlantic University School of Medicine. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Forsmark CE. Pancreatitis. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 130.

Siddiqi HA, Rabinowitz S, Axiotis CA. Laboratory diagnosis of gastrointestinal and pancreatic disorders. In: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Philadelphia, PA: Elsevier; 2022:chap 23.

Vege SS. Acute pancreatitis. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 11th ed. Philadelphia, PA: Elsevier; 2021:chap 58.